Psoriasis

"Psoriasis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Descriptor ID	D011565
MeSH Number(s)	C17.800.859.675
Concept/Terms	Psoriasis Psoriasis Psoriases Pustulosis of Palms and Soles Pustulosis of Palms and Soles Pustulosis Palmaris et Plantaris Palmoplantaris Pustulosis Pustular Psoriasis of Palms and Soles

Below are MeSH descriptors whose meaning is more general than "Psoriasis".

Diseases [C]
Skin and Connective Tissue Diseases [C17]
Skin Diseases [C17.800]
Skin Diseases, Papulosquamous [C17.800.859]
Psoriasis [C17.800.859.675]

Below are MeSH descriptors whose meaning is related to "Psoriasis".

Below are MeSH descriptors whose meaning is more specific than "Psoriasis".

Psoriasis
Arthritis, Psoriatic

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Psoriasis" by people in this website by year, and whether "Psoriasis" was a major or minor topic of these publications.

Bar chart showing 41 publications over 21 distinct years, with a maximum of 6 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	0	1
1998	1	0	1
2000	2	0	2
2002	1	1	2
2004	1	0	1
2005	1	0	1
2007	1	0	1
2008	3	0	3
2010	1	0	1
2012	1	1	2
2013	3	0	3
2014	1	0	1
2015	1	3	4
2016	0	1	1
2017	1	0	1
2018	1	2	3
2019	1	0	1
2020	6	0	6
2022	4	0	4
2023	1	0	1
2024	1	0	1

Below are the most recent publications written about "Psoriasis" by people in Profiles.

Surve D, Fish A, Debnath M, Pinjari A, Lorenzana A, Piya S, Peyton S, Kulkarni A. Sprayable inflammasome-inhibiting lipid nanorods in a polymeric scaffold for psoriasis therapy. Nat Commun. 2024 Oct 19; 15(1):9035.

View in: PubMed
Burden AD, Bissonnette R, Anatchkova M, Budhiarso I, Skalicky AM, Liberato ACS, Hu N, Thoma C, Gloede T, Kohlmann T, Lebwohl MG. Psychometric validation of the Psoriasis Symptom Scale, Functional Assessment of Chronic Illness Therapy-Fatigue and pain-Visual Analogue Scale in patients with generalized pustular psoriasis. J Eur Acad Dermatol Venereol. 2024 Jul; 38(7):1383-1390.

View in: PubMed
Nicolas SE, Bear MD, Kanaan AO, Coman OA, Dima L. Roflumilast 0.3% Cream: a Phosphodiesterase 4 Inhibitor for the Treatment of Chronic Plaque Psoriasis. Am J Ther. 2023 Nov-Dec 01; 30(6):e535-e542.

View in: PubMed
Burden AD, Bissonnette R, Lebwohl MG, Gloede T, Anatchkova M, Budhiarso I, Hu N, Thoma C, Skalicky AM, Bachelez H. Psychometric validation of the generalized pustular psoriasis physician global assessment (GPPGA) and generalized pustular psoriasis area and severity index (GPPASI). J Eur Acad Dermatol Venereol. 2023 Jul; 37(7):1327-1335.

View in: PubMed
Whitley SK, Li M, Kashem SW, Hirai T, Igy?rt? BZ, Knizner K, Ho J, Ferris LK, Weaver CT, Cua DJ, McGeachy MJ, Kaplan DH. Local IL-23 is required for proliferation and retention of skin-resident memory TH17 cells. Sci Immunol. 2022 11 18; 7(77):eabq3254.

View in: PubMed
Levin NA, Rashighi M. Psoriasis and hidradenitis suppurativa are associated with inflammatory bowel disease: a growing body of evidence. Br J Dermatol. 2022 11; 187(5):631-632.

View in: PubMed
Menter A, Cohen S, Kay J, Strand V, Gottlieb A, Hanauer S, Eduru SK, Buschke S, Lang B, Liesenfeld KH, Schaible J, McCabe D. Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial. Am J Clin Dermatol. 2022 Sep; 23(5):719-728.

View in: PubMed
Patel D, Svoboda R, Maczuga S, Foulke GT, Helm M. A retrospective claims analysis confirms the cost of most biologic agents for psoriasis is increasing more rapidly than medical inflation. J Am Acad Dermatol. 2023 02; 88(2):490-493.

View in: PubMed
Daniel VT, Blankenship KC, Daly RF, Tkachenko E, Morss-Walton PC, Levin NA. Low rate of conversion to positive tuberculosis status among patients with psoriasis on biologic therapies: A retrospective study from a US academic medical center. J Am Acad Dermatol. 2021 Mar; 84(3):830-833.

View in: PubMed
Evans EA, Sayers SR, Kodji X, Xia Y, Shaikh M, Rizvi A, Frame J, Brain SD, Philpott MP, Hannen RF, Caton PW. Psoriatic skin inflammation induces a pre-diabetic phenotype via the endocrine actions of skin secretome. Mol Metab. 2020 11; 41:101047.

View in: PubMed

People

Explore

Similar Concepts

Top Journals